Una vacuna no bastará para combatir el covid, dice jefe de Novartis
Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes
Novartis CEO Steers Drug Maker Back to R&D - WSJ
El CEO Vasant Narasimhan del fabricante suizo de drogas Novartis hace un discurso durante la ceremonia de apertura de la nueva fábrica de terapia celular y génica de la compañía en Stein,
El antiviral de Novartis reduce un 78% el ingreso por covid
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Vasant Narasimhan | Novartis
Novartis 2019: habla el CEO | PharmaBiz.NET
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin
Basel is very open to newcomers - Basel Area Business & Innovation
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Es demasiado pronto para declarar al Covid endémico, dice el CEO de Novartis Narasimhan - Salud News
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
21 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
CEO of Novartis pinning hopes on malaria drug - Basel Area Business & Innovation
Novartis CEO Vas Narasimhan urges global push for free and open movement of trade and talent - The Hindu BusinessLine
